Market Research Manager at Industry Standard Research Patrick Olsen discusses ISR’s recent small & emerging biopharma research activities, identifying their specific needs and how they differ from those of larger sponsors.
“When looking at the attributes individually, small and emerging biopharma respondents were more uniform in their attribute selection compared to larger companies. This may be a result of smaller companies sharing similar outsourcing priorities and needs. Of the 28 attributes included in the study, only three attributes received 10 percent or more of respondents’ votes as most important among small and emerging companies and larger companies.”
Read more at Bioprocess Online, and be sure to check out our Small Molecule API Contract Manufacturer Quality Benchmarking: A Look at Small & Emerging Biopharma report for more information on ISR’s small & emerging biopharma research efforts.